Alaunos Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Alaunos Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q4 2023.
  • Alaunos Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$2.14M -100% Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.04M -$1.21M -53.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.43M -$923K -39.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.02M -$2.22M -52.3% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $2.14M -$2.28M -51.7% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $2.25M -$2.93M -56.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.36M -$3.01M -56.1% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $4.24M -$117K -2.69% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $4.42M -$230K -4.95% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $5.18M +$2.81M +119% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $5.37M +$3.49M +185% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $4.36M +$2.28M +110% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $4.65M +$2.38M +105% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $2.37M +$1.09M +84.7% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.88M +$445K +30.9% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $2.08M +$490K +30.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $2.27M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $1.28M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $1.44M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.59M Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.